United States Adalimumab Biosimilar Industry 2016 Market Research Report

QYResearchが発行した調査報告書(QYR60927969)
◆商品コード:QYR60927969
◆発行会社(リサーチ会社):QYResearch
◆発行日:2016年8月2日
◆ページ数:130
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single UserUSD3,800 ⇒換算¥429,400見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD7,600 ⇒換算¥858,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

The United States Adalimumab Biosimilar Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Adalimumab Biosimilar industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Adalimumab Biosimilar market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Adalimumab Biosimilar industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 153 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

【レポートの目次】

Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Adalimumab Biosimilar
1.1.1 Definition of Adalimumab Biosimilar
1.1.2 Specifications of Adalimumab Biosimilar
1.2 Classification of Adalimumab Biosimilar
1.3 Applications of Adalimumab Biosimilar
1.3.1 Rheumatoid Arthritis
1.3.2 Ankylosing Sporidylitis
1.3.3 Psoriasis
1.4 Industry Chain Structure of Adalimumab Biosimilar
1.5 Industry Overview of Adalimumab Biosimilar
1.6 Industry Policy Analysis of Adalimumab Biosimilar
1.7 Industry News Analysis of Adalimumab Biosimilar

2 Manufacturing Cost Structure Analysis of Adalimumab Biosimilar
2.1 Bill of Materials (BOM) of Adalimumab Biosimilar
2.2 BOM Price Analysis of Adalimumab Biosimilar
2.3 Labor Cost Analysis of Adalimumab Biosimilar
2.4 Depreciation Cost Analysis of Adalimumab Biosimilar
2.5 Manufacturing Cost Structure Analysis of Adalimumab Biosimilar
2.6 Manufacturing Process Analysis of Adalimumab Biosimilar
2.7 United States Price, Cost and Gross of Adalimumab Biosimilar 2011-2016

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Adalimumab Biosimilar Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Adalimumab Biosimilar Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Adalimumab Biosimilar Key Manufacturers in 2015

4 Production Analysis of Adalimumab Biosimilar by Regions, Type, and Applications
4.1 United States Production of Adalimumab Biosimilar by Regions 2011-2016
4.2 United States Production of Adalimumab Biosimilar by Type 2011-2016
4.3 United States Sales of Adalimumab Biosimilar by Applications 2011-2016
4.4 Price Analysis of United States Adalimumab Biosimilar Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Adalimumab Biosimilar 2011-2016

5 Consumption Volume and Consumption Value Analysis of Adalimumab Biosimilar by Regions
5.1 United States Consumption Volume of Adalimumab Biosimilar by Regions 2011-2016
5.2 United States Consumption Value of Adalimumab Biosimilar by Regions 2011-2016
5.3 United States Consumption Price Analysis of Adalimumab Biosimilar by Regions 2011-2016

6 Analysis of Adalimumab Biosimilar Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Adalimumab Biosimilar 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Adalimumab Biosimilar 2014-2015
6.3 Sales Overview of Adalimumab Biosimilar 2011-2016
6.4 Supply, Consumption and Gap of Adalimumab Biosimilar 2011-2016
6.5 Import, Export and Consumption of Adalimumab Biosimilar 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Adalimumab Biosimilar 2011-2016

7 Analysis of Adalimumab Biosimilar Industry Key Manufacturers
7.1 Zydus Cadila
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Adalimumab Biosimilar Product Types
8.5 Market Share Analysis of Different Adalimumab Biosimilar Price Levels
8.6 Gross Margin Analysis of Different Adalimumab Biosimilar Applications

9 Marketing Trader or Distributor Analysis of Adalimumab Biosimilar
9.1 Marketing Channels Status of Adalimumab Biosimilar
9.2 Traders or Distributors of Adalimumab Biosimilar with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Adalimumab Biosimilar
9.4 United States Import, Export and Trade Analysis of Adalimumab Biosimilar

10 Development Trend of Adalimumab Biosimilar Industry 2016-2021
10.1 Capacity and Production Overview of Adalimumab Biosimilar 2016-2021
10.2 Production Market Share by Product Types of Adalimumab Biosimilar 2016-2021
10.3 Sales and Sales Revenue Overview of Adalimumab Biosimilar 2016-2021
10.4 United States Sales of Adalimumab Biosimilar by Applications 2016-2021
10.5 Import, Export and Consumption of Adalimumab Biosimilar 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Adalimumab Biosimilar 2016-2021

11 Industry Chain Suppliers of Adalimumab Biosimilar with Contact Information
11.1 Major Raw Materials Suppliers of Adalimumab Biosimilar with Contact Information
11.2 Manufacturing Equipment Suppliers of Adalimumab Biosimilar with Contact Information
11.3 Major Players of Adalimumab Biosimilar with Contact Information
11.4 Key Consumers of Adalimumab Biosimilar with Contact Information
11.5 Supply Chain Relationship Analysis of Adalimumab Biosimilar

12 New Project Investment Feasibility Analysis of Adalimumab Biosimilar
12.1 New Project SWOT Analysis of Adalimumab Biosimilar
12.2 New Project Investment Feasibility Analysis of Adalimumab Biosimilar

13 Conclusion of the United States Adalimumab Biosimilar Industry 2016 Market Research Report

List of Tables and Figures

Figure Picture of Adalimumab Biosimilar
Table Product Specifications of Adalimumab Biosimilar
Table Classification of Adalimumab Biosimilar
Figure United States Sales Market Share of Adalimumab Biosimilar by Product Types in 2015
Table Applications of Adalimumab Biosimilar
Figure United States Sales Market Share of Adalimumab Biosimilar by Applications in 2015
Figure Industry Chain Structure of Adalimumab Biosimilar
Table United States Industry Overview of Adalimumab Biosimilar
Table Industry Policy of Adalimumab Biosimilar
Table Industry News List of Adalimumab Biosimilar
Table Bill of Materials (BOM) of Adalimumab Biosimilar
Table Bill of Materials (BOM) Price of Adalimumab Biosimilar
Table Labor Cost of Adalimumab Biosimilar
Table Depreciation Cost of Adalimumab Biosimilar
Table Manufacturing Cost Structure Analysis of Adalimumab Biosimilar in 2015
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Table United States Price Analysis of Adalimumab Biosimilar 2011-2016 (USD/Unit)
Table United States Cost Analysis of Adalimumab Biosimilar 2011-2016 (USD/Unit)
Table United States Gross Analysis of Adalimumab Biosimilar 2011-2016
Table Capacity (Unit) and Commercial Production Date of United States Adalimumab Biosimilar Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Adalimumab Biosimilar Manufacturers in 2015
Table R&D Status and Technology Source of United States Adalimumab Biosimilar Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Adalimumab Biosimilar Key Manufacturers in 2015
Table United States Production of Adalimumab Biosimilar by Regions 2011-2016 (Unit)
Table United States Production Market Share of Adalimumab Biosimilar by Regions 2011-2016
Figure United States Production Market Share of Adalimumab Biosimilar by Regions in 2014
Figure United States Production Market Share of Adalimumab Biosimilar by Regions in 2015
Table United States Production of Adalimumab Biosimilar by Types in 2011-2016 (Unit)
Table United States Production Market Share of Adalimumab Biosimilar by Type in 2011-2016
Figure United States Production Market Share of Adalimumab Biosimilar by Type in 2014
Figure United States Production Market Share of Adalimumab Biosimilar by Type in 2015
Table United States Sales of Adalimumab Biosimilar by Applications 2011-2016 (Unit)
Table United States Production Market Share of Adalimumab Biosimilar by Applications 2011-2016
Figure United States Production Market Share of Adalimumab Biosimilar by Applications in 2014
Figure United States Production Market Share of Adalimumab Biosimilar by Applications in 2015
Table Price Comparison of United States Adalimumab Biosimilar Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Adalimumab Biosimilar 2011-2016
Table United States Consumption Volume of Adalimumab Biosimilar by Regions 2011-2016 (Unit)
Table United States Consumption Volume Market Share of Adalimumab Biosimilar by Regions 2011-2016
Figure United States Consumption Volume Market Share of Adalimumab Biosimilar by Regions in 2014
Figure United States Consumption Volume Market Share of Adalimumab Biosimilar by Regions in 2015
Table United States Consumption Value of Adalimumab Biosimilar by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Adalimumab Biosimilar by Regions 2011-2016
Figure United States Consumption Value Market Share of Adalimumab Biosimilar by Regions in 2014
Figure United States Consumption Value Market Share of Adalimumab Biosimilar by Regions in 2015
Table Consumption Price of Adalimumab Biosimilar by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Adalimumab Biosimilar 2011-2016 (Unit)
Table United States Capacity Market Share of Major Adalimumab Biosimilar Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Adalimumab Biosimilar 2011-2016 (Unit)
Table United States Production Market Share of Major Adalimumab Biosimilar Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Adalimumab Biosimilar 2011-2016 (Unit)
Table United States Sales Market Share of Major Adalimumab Biosimilar Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Adalimumab Biosimilar 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Adalimumab Biosimilar Manufacturers 2011-2016
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Adalimumab Biosimilar 2011-2016
Figure United States Capacity Utilization Rate of Adalimumab Biosimilar 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Adalimumab Biosimilar 2011-2016
Figure United States Production Market Share of Major Adalimumab Biosimilar Manufacturers in 2014
Figure United States Production Market Share of Major Adalimumab Biosimilar Manufacturers in 2015
Figure United States Sales Market Share of Major Adalimumab Biosimilar Manufacturers in 2014
Figure United States Sales Market Share of Major Adalimumab Biosimilar Manufacturers in 2015
Figure United States Sales (Unit) and Growth Rate of Adalimumab Biosimilar 2011-2016
Table United States Supply, Consumption and Gap of Adalimumab Biosimilar 2011-2016 (Unit)
Table United States Import, Export and Consumption of Adalimumab Biosimilar 2011-2016 (Unit)
Table Price of United States Adalimumab Biosimilar Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Adalimumab Biosimilar Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Adalimumab Biosimilar 2011-2016 (M USD)
Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Adalimumab Biosimilar 2011-2016
Table Zydus Cadila Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Adalimumab Biosimilar Picture and Specifications of Zydus Cadila
Table Adalimumab Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Zydus Cadila 2011-2016
Figure Adalimumab Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Zydus Cadila 2011-2016
Figure Adalimumab Biosimilar Production (Unit) and United States Market Share of Zydus Cadila 2011-2016
Table Zydus Cadila Adalimumab Biosimilar SWOT Analysis
Table Adalimumab Biosimilar Price by Regions 2011-2016
Table Adalimumab Biosimilar Price by Product Types 2011-2016
Table Adalimumab Biosimilar Price by Companies 2011-2016
Table Adalimumab Biosimilar Gross Margin by Companies 2011-2016
Table Price Comparison of Adalimumab Biosimilar by Regions 2011-2016 (USD/Unit)
Table Price of Different Adalimumab Biosimilar Product Types (USD/Unit)
Table Market Share of Different Adalimumab Biosimilar Price Level
Table Gross Margin of Different Adalimumab Biosimilar Applications
Table Marketing Channels Status of Adalimumab Biosimilar
Table Traders or Distributors of Adalimumab Biosimilar with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Adalimumab Biosimilar (USD/Unit) in 2015
Table United States Import, Export, and Trade of Adalimumab Biosimilar (Unit)
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Adalimumab Biosimilar 2016-2021
Figure United States Capacity Utilization Rate of Adalimumab Biosimilar 2016-2021
Table United States Adalimumab Biosimilar Production by Type 2016-2021 (Unit)
Table United States Adalimumab Biosimilar Production Market Share by Type 2016-2021
Figure United States Production Market Share of Adalimumab Biosimilar by Type in 2021
Figure United States Sales (Unit) and Growth Rate of Adalimumab Biosimilar 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Adalimumab Biosimilar 2016-2021
Figure United States Sales of Adalimumab Biosimilar by Applications 2016-2021 (Unit)
Table United States Production Market Share of Adalimumab Biosimilar by Applications 2016-2021
Figure United States Production Market Share of Adalimumab Biosimilar by Applications in 2021
Table United States Production, Import, Export and Consumption of Adalimumab Biosimilar 2016-2021 (Unit)
Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Adalimumab Biosimilar 2016-2021
Table Major Raw Materials Suppliers of Adalimumab Biosimilar with Contact Information
Table Manufacturing Equipment Suppliers of Adalimumab Biosimilar with Contact Information
Table Major Players of Adalimumab Biosimilar with Contact Information
Table Key Consumers of Adalimumab Biosimilar with Contact Information
Table Supply Chain Relationship Analysis of Adalimumab Biosimilar
Table New Project SWOT Analysis of Adalimumab Biosimilar
Table New Project Investment Feasibility Analysis of Adalimumab Biosimilar
Table Part of Interviewees Record List


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ United States Adalimumab Biosimilar Industry 2016 Market Research Report]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆